{
  "timestamp": "20250103_194242",
  "model": "gpt-4o-mini",
  "interaction_type": "direct_answer",
  "question_id": "4a02a891",
  "question_text": "Which of the following does not cause Insulin release-",
  "messages": [
    {
      "role": "system",
      "content": "You are a medical expert making decisions based on medical knowledge."
    },
    {
      "role": "user",
      "content": "You are a medical expert specializing in the field of Pharmacology.Please help answer this multiple choice question:\n\nQuestion: Which of the following does not cause Insulin release-\n\nOptions:\nopa. Rosiglitazone\nopb. Nateglinide\nopc. Glimipiride\nopd. Tobutamide\n\n        ### Output Format\n        Provide your response in valid JSON format:\n        {   \n            \"final_analysis\": \"Your concise analysis following the above structure\",\n            \"answer\": \"Option key from the available options (only key,like opa)\",\n            \"confidence\": Score between 0-100 based on alignment with established medical facts\n        }\n        "
    }
  ],
  "response": "{\n    \"final_analysis\": \"Rosiglitazone is a thiazolidinedione that primarily works by increasing insulin sensitivity in peripheral tissues and does not directly stimulate insulin release from the pancreas. In contrast, Nateglinide, Glimepiride, and Tobutamide are all secretagogues that stimulate insulin release from pancreatic beta cells.\",\n    \"answer\": \"opa\",\n    \"confidence\": 90\n}",
  "metadata": {
    "topic": "Pharmacology",
    "is_multi_choice": true,
    "has_reasoning_chain": false,
    "has_enhanced_info": false,
    "model_config": "gpt-4o-mini",
    "temperature": 0.0
  }
}